Countries pledge $3.9 billion to Global Environment Facility
By PR Newswire
April 10, 2026 | 11:41
Donor nations committed funding for the multilateral environmental organization's ninth replenishment cycle supporting conservation and climate projects.
8fig extends funding to Temu sellers in US and Canada
By PR Newswire
April 10, 2026 | 11:28
The e-commerce financing platform expanded services supporting merchants selling on the Chinese marketplace across North American markets.
DualityBio files China application for breast cancer therapy
By PR Newswire
April 10, 2026 | 11:22
The Chinese biotechnology company submitted regulatory paperwork seeking approval for trastuzumab pamirtecan treating HER2-positive tumors.
FDA accepts Telix brain cancer imaging drug application
By PR Newswire
April 10, 2026 | 10:42
The US regulator formally received the Australian company's new drug application for its TLX101-Px diagnostic imaging agent beginning review.
STRADVISION files for KOSDAQ IPO with 7 million shares
By PR Newswire
April 10, 2026 | 10:38
The automotive AI camera technology company submitted listing applications to South Korea's technology stock exchange for public offering.
Kia outlines EV expansion at 2026 investor day
By PR Newswire
April 10, 2026 | 10:27
The South Korean automaker presented strategic plans for electrified vehicle portfolio growth and manufacturing capabilities to shareholders.
Global insolvencies to rise 3% in 2026, Atradius forecasts
By PR Newswire
April 10, 2026 | 09:20
The credit insurance provider predicted continued elevation in corporate bankruptcies worldwide as economic pressures persist through the year.
OncoC4 begins phase 1/2 Alzheimer's trial dosing
By PR Newswire
April 10, 2026 | 09:16
The biotechnology company administered its ONC-841 candidate to the initial patient in early-to-mid-stage testing for the neurodegenerative disease.
Gan & Lee licenses diabetes drug to JW Pharmaceutical
By PR Newswire
April 10, 2026 | 09:13
The Chinese pharmaceutical company granted the South Korean partner exclusive rights to commercialize its GLP-1 receptor agonist Bofanglutide internationally.
Oricell Therapeutics raises $110 million for solid tumor CAR-T
By PR Newswire
April 10, 2026 | 09:09
The cell therapy company secured pre-listing funding to advance clinical development of engineered immune treatments for non-blood cancers globally.
China to approve world's first solid tumor CAR-T therapy
By PR Newswire
April 10, 2026 | 09:04
Regulatory clearance for the engineered immune cell treatment targeting non-blood cancers is expected imminently in the country.
Acer March revenue hits NT$29.9 billion, up 39.3%
By PR Newswire
April 10, 2026 | 08:57
The Taiwanese computer manufacturer reported its strongest March sales since the pandemic with substantial sequential growth from February.
Terra Quantum AG to go public in $3.25 billion SPAC deal
By PR Newswire
April 10, 2026 | 08:52
The Swiss quantum computing company agreed to list through a special purpose acquisition company transaction valuing the firm at the amount.
Mobile Version